Anti-BST2 antibody
Specifications
| Product type: | Primary antibody |
| Antigen: | BST2 |
| Immunogen: | Recombinant protein |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:500); Immunohistochemistry (1:100-1:200); Flow Cytometry (1:40-1:100) |
| Reactivity: | Human |
| Clonality (clone number): | Monoclonal, JU11-93 |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 1% BSA, 40% glycerol, 0.05% NaN3. |
| Concentration: | 1mg/ml |
| Purity: | Protein A/G affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | Bone marrow stromal antigen 2 antibody |
| Bone marrow stromal cell antigen 2 antibody | |
| Bone marrow stromal cell antigen antibody | |
| BST 2 antibody | |
| BST-2 antibody | |
| BST2 antibody | |
| BST2_HUMAN antibody | |
| CD 317 antibody | |
| CD317 antibody | |
| CD317 antigen antibody | |
| HM1.24 antigen antibody | |
| NPC A 7 antibody | |
| Tetherin antibody |
Show More
Target information
May be involved in the sorting of secreted proteins. May be involved in pre-B-cell growth. Antiretroviral defense protein, that blocks release of retrovirus from the cell surface. Depleted unpon HIV-1 infection by viral VPU protein through 20S proteasome degradation. Depleted upon infection by human Kaposi’s sarcoma-associated herpesvirus (KSHV) through ubiquitination and subsequent degradation. May play a role in B-cell activation in rheumatoid arthritis.
Provider
Erpantech Laboratory